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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S288were analyzed using descriptive and bivariate test, parametric and
no-parametric statistical tests were used.
Results: We studied 72 patients, mean age 45 years  7.4, 83% female
gender, education (years) mean 10.5  3.8, Body Mass Index 30.6  4.9.
Score for WOMAC were: pain 1.4, stiffness 1.5, physical function 1.3.
EuroQol 0.55 in male population vs. 0.69 in women population. The
table 1 show MSUS ﬁndings.
Conclusions:morpho-structural ﬁndings byMSUSwere found in a high
prevalence of patients with knee OA classiﬁed by radiology in early
stages. This shows that although radiology is the most used method for
classiﬁcation of disease, it does not evaluate an early OA, further studies
are required to detect early changes of OA.Figure legend. In CIA rats, therapeutic effects of siCx43. Cumulative
incidence of paw swelling (A) and kinetic change of paw volume (mean 
SD) (B) are plotted, *p < 0.05, versus the siNeg, # p < 0.05, versus the
control. Representative microscopic images of H&E and Safranin O-stained
saggital sections (C) are shown (black bars ¼ 1 mm).Inﬂammation and Immunity
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ADIPOKINES INDUCE INFLAMMATORY MEDIATORS IN CD4D T CELLS
AND MODULATE THE CROSS TALK BETWEEN CD4D T LYMPHOCYTES
AND CHONDROCYTES FROM OA PATIENTS.
M. Scotece y, J. Conde y, V. Abella y,z, V. Lopez y, V. Lazzaro y,x, J. Pino y,
J.J. Gomez-Reino y, O. Gualillo y. y SERGAS-IDIS Santiago Univ. Clinical
Hosp., Santiago de Compostela, Spain; zUniv. of A Coru~na, A Coru~na,
Spain; xUniversita della Magna Grecia, Catanzaro, Italy
Purpose: Osteoarthritis (OA) is a progressive disease of the joints
characterized by degradation of articular cartilage. Although OA is
commonly described as non-inﬂammatory disease, inﬂammation is
recognized as contributing to the symptoms and progression of OA. One
of the symptoms of OA is synovitis. Pro-inﬂammatory cytokines are
produced in the inﬂamed synovium and diffuse into the cartilage,
activating chondrocytes that in turn could produce catabolic factors
that might contribute to the destruction of extra cellular matrix (ECM).
In addition, several studies suggest that adipokines, such as leptin and
adiponectin, are involved in the pathophysiology of OA. However, the
role of immune component in osteoarthritis is still obscure and poorly
investigated. In order to gain further insights into the potential inter-
action of immune cells in OA and the role of adipokines on these cells,
we have performed a series of experiments in CD4þ T cells from OA
patients. Namely, we ﬁrst evaluated the in vitro proliferative effect of
several adipokines (adiponectin, lipocalin-2 and leptin) on CD4þ T cells
from OA patients. Next, we evaluated whether adipokines were able to
induce activation of these cells by inducing CD69 and CD25. Finally, we
also investigated the modulation of several inﬂammatory mediators in
these cells. For completeness, the cross talk between activated CD4þ T
cells and chondrocytes from OA patients, in presence or not of adipo-
kines, was also explored.
Methods: Peripheral blood samples were collected from OA patients.
PBMCs were obtained by Ficoll Paque and CD4þ T cells were magneti-
cally puriﬁed (Invitrogen). Proliferation was evaluated by CFSE assay
and the activation by ﬂow cytometry (CD25, CD69). CD4þ T cells were
plated, stimulated with anti-CD3/CD28, in the presence or not of adi-
pokines, during several days. mRNA and protein expression of inﬂam-
matory factors was evaluated by qRT-PCR and ELISA assays. To test the
cross talk between T lymphocytes and chondrocytes, primary chon-
drocytes were harvested from human OA articular cartilage samples,
and co-cultured with activated CD4þ T cells in two ways: the ﬁrst way
by incubating the cells by direct contact or by transwell system and
afterwards treated or not with recombinant adipokines during several
days.
Results: Adipokines induce the proliferation and activation of CD4þ T
cells from OA patients. The exposure of activated CD4þ T cells to adi-
ponectin, lipocalin-2 and leptin, during several days, modulates IL-6, IL-
8 and CCL-3 production. On the other hand, we observed that the
production of macromolecules of ECM, such as aggrecan, in co-cultured
chondrocytes with activated CD4þ T cells, in presence or not of adi-
pokines, was altered.
Conclusions: This study showed that there is a clear cross talk between
T cells and chondrocytes and that this interaction is modulated by
adipokines. Our results might contribute to enlighten the under-
standing of still unclear immune-mediated mechanism/s in OA.501
THE ROLES OF CONNEXIN 43 IN EXPERIMENTAL ARTHRITIS
S. Tsuchida, Y. Arai, S. Nakagawa, R. Terauchi, K. Honjo, H. Inoue,
D. Tokunaga, O. Mazda, T. Kubo. Kyoto Prefectural Univ. of Med., Kyoto,
Japan
Purpose: Connexin 43 (Cx43), a major component of gap-junction
channels of human synovium, is abundantly expressed in synoviocytes.
Cx43 plays an important role in the regulation of various immune
processes. It has been reported that Cx43 was upregulated in various
tissue or cells by inﬂammatory stimuli, and that silencing of Cx43
downregulated the inﬂammatory response. In previously, we showed
that Cx43 was enhanced in arthritis synovial membranes. These reports
suggest that Cx43 may be involved in arthritis pathophysiology, and
that inhibition of Cx43 may ameliorate arthritis. Therefore, we exam-
ined the effects of small interfering RNA (siRNA) targeting Cx43 in
experimental arthritis.
Methods: A rat model of collagen-induced arthritis (CIA) was used for
experimental arthritis. The therapeutic effects of siRNA targeting Cx43
(siCx43) or non-speciﬁc siRNA (siNeg) in CIA rats were examined by in
vivo electroporation method. Each siRNA was transfected every 3 days
(i.e., on days 7, 10, 13, and 16 after immunization). To analyze Cx43
mRNA expression by real time reverse transcription-polymerase chain
reaction (RT- PCR), the synovium was removed from the region sur-
rounding the left patella and the ipsilateral ankle of CIA rats 16 days
after immunization. (n ¼ 4 per group) Foot volume of CIA rats were
measured. At 28 days post-immunization, the hind paw were stained
with hematoxylin and eosin (H&E), or safranin O. Histological score
were also obtained. (n ¼ 6 per group) The data were analyzed by using
the Tukey-Kramer test and the nonparametric Mann-Whitney U test. In
all analyses, P < 0.05 was deﬁned ad statistically signiﬁcant.
Results: The mean level of Cx43 mRNA expression in siCx43-treated
ﬁbroblast-like synoviocytes (FLS) was 11.0%  5.9% of that in cells treated
with siNeg. The expression of Cx43 in the knee joints treated in vivo with
siCx43 was signiﬁcantly lower than that in siNeg-treated joints, as was
the expression of Cx43 in the ipsilateral ankle joints. Treatment of left
lower limbs with siCx43 delayed the onset of symptoms compared with
